
    
      This study consisted of:

        -  Induction Period (dosing at Weeks 0, 2, and 4)

        -  Maintenance Dosing (dosing every 4 weeks up to Week 260)

        -  End of Treatment Visit that occurred at Week 262/Withdrawal Visit and a Safety Follow-up
           Visit (SFU; 12 weeks after final dose)
    
  